FDA — authorised 17 December 1973
- Application: NDA016729
- Marketing authorisation holder: MALLINCKRODT
- Local brand name: FERROUS CITRATE FE 59
- Indication: INJECTABLE — INJECTION
- Status: approved
🇺🇸 FERROUS CITRATE FE 59 in United States
FDA authorised FERROUS CITRATE FE 59 on 17 December 1973
Marketing authorisations
FDA
- Status: approved
FERROUS CITRATE FE 59 in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is FERROUS CITRATE FE 59 approved in United States?
Yes. FDA authorised it on 17 December 1973; FDA has authorised it.
Who is the marketing authorisation holder for FERROUS CITRATE FE 59 in United States?
MALLINCKRODT holds the US marketing authorisation.